Elizabeth Spurgin of B&D; Consulting will be a participating in the discussion on "Planning for Reimbursement." This session takes place on February 26, 2010 at 10:35 a.m. Liz also speaks on the reimbursement environment for novel epilepsy treatments in a panel entitled "Reimbursement and Regulatory Issues: Novel & Modified Drugs, Stimulators & Drug Delivery Systems." This session takes place on February 26, 2010 at 11:30 a.m.
During the conference, participants will hear insights from scientific, clinical and industry leaders relevant to investment in epilepsy and broader CNS areas.
Transmission of information to us via this feature does not establish a privileged relationship. Do not send any information that you would have treated confidentially.